Bret Bostwick, a physician-scientist and venture partner at Breyer Capital, argues that the hardest problem in CNS drug development is not finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results